Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Add Photo/Video
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Donatos Pizza

Updated: February 24, 2021 12:00 PM
The employer has not taken the appropriate steps to protect employees from SARS-CoV-2, the virus that causes COVID-19. A third employee has tested positive for COVID-19. The company is also using outdated CDC guidelines to inform workers of COVID cases, as well as using outdated guidelines to... See More diagnose the worker who tested positive. Donatos qualifies close contact if exposure was within 6 feet and unmasked for 15 minutes. CDC guidelines are to inform employees of their possible close contact, mask or no mask, (within 6 feet of an infected person for a cumulative total of 15 minutes or more over a 24-hour period) with someone with confirmed or suspected SARS-CoV-2 infection in the workplace, but maintain confidentiality. No employees that were within close contact of the COVID case were informed of the fact that they had exposure/contact for two days.

Alleged Hazards: 1, Employees Exposed: 20
Source: Osha.gov | Receipt Date: 2021-02-03
See Less
1.6K


Recent Interesting Reports

1.5 years no tenant. Overgrown lawn, door falling off hinges. Lowering property values and turning area into ghetto See Less
404


Hauppauge, NY, Loud Muscle Science, LLC is voluntarily recalling the following Launch Sequence products and lots listed in the table below to the consumer level. Laboratory analysis undertaken at the request of Loud Muscle Science, LLC found the products to be tainted with tadalafil, an ingredient in... See More FDA approved products for treatment of male erectile dysfunction in the family of drugs known as phosphodiesterase (PDE-5) inhibitors. The presence of tadalafil in the Launch Sequence products makes these products unapproved drugs for which the safety and efficacy have not been established and therefore, subject to recall.

Risk Statement: The most critical potential adverse health consequence of unintentional consumption of a product tainted with undeclared tadalafil is profound, life-threatening hypotension related to drug-drug interactions with nitroglycerin or guanylate cyclase inhibitors.

In the expected-use population, profound hypotension can result in a heart attack, stroke or death. To date, Loud Muscle Science has not received any reports of adverse events related to this recall. These tainted Launch Sequence Capsule products are marketed as dietary supplements for male sexual enhancement. The affected products are:

- Launch Sequence Capsules. Package Size: 60. (Bottle) ASIN: B07TLPWXDS. UPC Code: 641378938375.
- Launch Sequence Euphoria Capsules. Package Size: 10. (Tin) ASIN: B08ZJX4V9J. UPC Code: 661020846864.
- Launch Sequence Aphrodisia Capsules. Package Size: 4. (Tin) ASIN: B07QB3S2LV. UPC Code: 661020846957.
- Launch Sequence Capsules. Package Size: 60. (Bottle) ASIN: B08HM7VHCX. UPC Code: 661020848166.
- Launch Sequence Euphoria Capsules. Package Size: 10. (Tin) ASIN: B08ZJX4V9J. UPC Code: 661020846864.
- Launch Sequence Aphrodisia Capsules. Package Size: 4. (Tin) ASIN: B09S12VK3F. UPC Code: 661020846957.

The full list of lots and expiry dates is available at the link below. The Launce Sequence capsule products were sold under Amazon ASIN Nos. B07TLPWXDS (USA 60 count) and B08HM7VHCX (Canada 60 count); Launch Sequence Euphoria capsule products were sold under Amazon ASIN Nos. B08ZJX4V9J (Euphoria USA 10 count) and B08ZJX4V9J (Euphoria Canada 10 count); and Launch Sequence Aphrodisia capsule products were sold under Amazon ASIN Nos. B07QB3S2LV (Aphrodisia USA 4 count) and B09S12VK3F (Aphrodisia Canada 4 count).

The products can be identified by the labels and packaging below. The product was marketed via the Internet and fulfilled by Amazon at www.amazon.com Nationwide in the USA and www.amazon.ca in Canada, on eBay.com, and in retail stores.

Loud Muscle Science is notifying its distributors and customers by letter and this press announcement and providing a refund to its customers. Consumers that have the Launch Sequence products should stop using the product and discard.

Consumers with questions regarding this recall can contact Loud Muscle Science, LLC by phone number: 631-270-4188 -- Monday through Friday 9AM – 4PM EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Company name: Loud Muscle Science, LLC
Brand name: Launch Sequence
Product recalled: Launch Sequence Aphrodisia and Euphoria Capsules
Reason of the recall: Contain Tadalafil
FDA Recall date: June 30, 2022

Source: fda.gov
See Less
441


There are several trees at Pinch Pond family campground that are either half or completely dead. I am concerned that with a strong storm a tree is going to fall on a camper or worse have someone in it! See Less
914


6/6/2022, at 2323:43 to be more precise. A significant and extensive sonic boom tore through our house, woke us, terrified our dogs and causes creaking that continued for several more seconds. It is not the “sound of freedom.” It is poor and unaware flying. It is also... See More profoundly disturbing especially in these crazy times. Our dogs didn’t settle for an hour. I didn’t settle until almost 3 am. This can’t be allowed by city ordinance. Extremely disruptive. I do have it on our doorbell and on inside house camera. It was so loud, it tripped the recordings. See Less
36


Green Pharmaceuticals Inc is voluntarily recalling lot 2373/21222 of SnoreStop NasoSpray, packaged in 0.3 FL OZ (9ml) bottles to the consumer level. FDA testing found product to contain microbial contamination identified as Providencia rettgeri. To date, Green Pharmaceuticals Inc has not received any reports of adverse events... See More related to this recalled lot.

This microorganism is rarely associated with human illness; however, in immunocompromised patients, the use of the recalled product could potentially result in severe or life-threatening adverse events such as bacteremia/sepsis, pneumonia, invasive fungal rhinosinusitis, or disseminated fungal infection. In non-immunocompromised patients, the use of the recalled product may result in infectious complications that are expected to be less severe and more readily responsive to treatment.

The product is used as a nasal spray to temporarily help stop or reduce symptoms of non-apneic snoring and is packaged in one single unit plastic bottle with a nasal pump as a delivery system. The affected SnoreStop NasoSpray lot includes the following: 2372/21222 (2373 is printed on a sticker placed on the bottom of the bottle and 21222 is on a sticker placed on the outer packaging).

The product can be identified by a clear transparent plastic box with the name SnoreStop NasoSpray. The product was distributed nationwide in health food stores and online. Green Pharmaceuticals Inc is notifying its retailers and customers by email and is arranging for return and replacement of all recalled products. Consumers and retailers that have product which is being recalled should stop using and return to place of purchase.

Consumers with questions regarding this recall can contact Green Pharmaceuticals Inc by phone at 805-388- 0600, Monday through Friday, 8 AM to 5 PM Pacific Standard Time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Company name: Green Pharmaceuticals Inc
Brand name: SnoreStop
Product recalled: Nasal spray
Reason of the recall: Due to microbial contamination identified as Providencia rettgeri.
FDA Recall date: June 09, 2022

Source: fda.gov
See Less
441


Plastikon Healthcare, LLC is voluntarily recalling one (1) lot of Milk of Magnesia 2400 mg/10 mL Oral Suspension, one (1) lot of Milk of Magnesia 2400 mg/30 mL Oral Suspension, eleven (11) lots of Magnesium Hydroxide 1200 mg/Aluminum Hydroxide 1200 mg/Simethicone 120 mg per 30 mL Oral... See More Suspension, and two (2) lots of Magnesium Hydroxide 2400 mg/Aluminum Hydroxide 2400 mg/Simethicone 240 mg per 30 mL Oral Suspension to the consumer level. The products are being recalled due to microbial contamination. To date, Plastikon Healthcare has not received any reports of adverse events or injuries related to this recall.

Risk Statement: Administration or use of oral drug products with microbial contamination could potentially result in increased infections that may require medical intervention. Patients with compromised immune systems, such as patients in hospitals and nursing homes, have a higher probability of developing potentially life-threatening infections after taking a contaminated product.

Product indication, lot numbers, expiration dates, and NDC information are listed in the link below. The products are packaged for institutional use and are sold to clinics and hospitals nationwide in single use cups with a foil lid. The affected lots were distributed to Major Pharmaceuticals Distribution Center (wholesaler) between 7/1/2020 and 10/31/2021, who shipped to hospitals, nursing homes, and clinics nationwide. The products are private labeled for Major Pharmaceuticals.

Plastikon Healthcare is notifying its direct customers via a recall letter to arrange for return of any recalled product. Anyone with an existing inventory of the lots which are being recalled should stop use and distribution, and quarantine immediately. Return all quarantined product to the place of purchase. For clinics, hospitals, or healthcare providers that have dispensed product to patients, please notify patients regarding the recall.

Consumers with questions regarding this recall can contact Plastikon Healthcare by phone at (785) 330-7109 Monday through Friday from 9 am to 4 pm CST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Company name: Plastikon Healthcare, LLC
Brand name: Plastikon Healthcare, LLC
Product recalled: Milk of Magnesia, Magnisium Hydroxide/Aluminum Hydroxide/Simethicone Oral Suspension
Reason of the recall: Due to microbial contamination
FDA Recall date: June 08, 2022

Source: fda.gov
See Less
442


Vi-Jon, LLC is voluntarily recalling 1 (one) lot of CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor, 10 FL OZ (296 mL) to the consumer level. Testing identified the affected lot of the product to contain the bacteria Gluconacetobacter liquefaciens. This lot of Magnesium Citrate Saline... See More Laxative Oral Solution Lemon Flavor was distributed Nationwide at CVS drug store locations.

Risk Statement: Immunocompromised patients, who consume this product, may be at increased risk for invasive infections caused by Gluconacetobacter liquefaciens that could lead to serious, life threatening adverse health consequences. To date, Vi-Jon, LLC has not received any complaints related to this recall. The product is used for relief of occasional constipation (irregularity) and generally produces bowel movement in 1/2 to 6 hours.

The product is packaged in a 10 oz clear round plastic bottle. The affected CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor lot includes the following batch number: 0556808 and expiration date: 12/2023 on the shoulder of the bottle. This lot of Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor was sent to a 3rd Party Outside Lab for testing per CVS request as a first production sample for CVS.

Vi-Jon, LLC has already notified CVS by phone and email and is arranging for return of all recalled product. Consumers that have this recalled product should stop using and return any remaining product to the place of purchase.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

In case you experienced harm this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance.

Company name: Vi-Jon, LLC
Brand name: CVS Health
Product recalled: Magnesium Citrate Saline Laxative Oral Solution, Lemon Flavor
Reason of the recall: Microbial contamination with Gluconacetobacter liquefaciens
FDA Recall date: June 22, 2022

Source: fda.gov
See Less
442


Last 30 days